Global G-Protein Coupled Receptors (GPCRs) Market - Industry Trends and Forecast to 2028

Market Analysis and Insights of G-Protein Coupled Receptors (GPCRs) Market

Data Bridge Market Research analyses that the G-protein coupled receptors (GPCRs) market will exhibit a CAGR of around 6.40% for the forecast period of 2021-2028. Rising prevalence of cardiovascular diseases, rising advancement in technology involved in cryotherapy equipment and rising expenditure for research and development proficiencies for the progress of novel drugs are the major factors attributable to the growth of the G-protein coupled receptors (GPCRs) market.

G-protein coupled receptors (GPCRs) are a diverse group of membrane receptors which are also known as seven-(pass)-trans membrane. These are located in the cell membrane and perform the function of binding extracellular substances and transmit signals from these substances to an intracellular molecule.

Rising prevalence of cardiovascular diseases is one of the major factors fostering the growth of G-protein coupled receptors (GPCRs) market. Rising expenditure for research and development activities for the development of novel pharmaceutical drugs and therapies is another indirect market growth determinant. Prevalence of large number of approved pharmaceutical drugs which targets theses receptors is also acting as an important factor bolstering the growth of the market.

However, high costs associated with G-protein coupled receptors (GPCRs) cell lines will act as a major market growth restraint. Unfavourable reimbursement policies especially in the developing economies will further pose challenges for the market growth. Dearth of skilled professionals or trained expertise will further derail the market growth rate. Stringent regulations and norms on the approval process will also obstruct the market growth.  

This G-protein coupled receptors (GPCRs) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on G-protein coupled receptors (GPCRs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global G-Protein Coupled Receptors (GPCRs) Market Scope and Market Size

The G-protein coupled receptors (GPCRs) market is segmented on the basis of product, assay type and therapeutic area. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on product, the global G-protein coupled receptors (GPCRs) market has been divided into cell lines, detection kits, cell culture reagents and ligands.
• Based on the assay type, the G-protein coupled receptors (GPCRs) market has been segmented as cAMP functional assays, calcium functional assays, β-arrestin functional assays, radioligand binding and GTPγS functional assays, internalization assays, trafficking assays and other assays.
• On the basis of therapeutic area, the G-protein coupled receptors (GPCRs)market is segmented into cardiovascular system, central nervous system, respiratory system, immune system, reproductive system, oncology, others.

G-Protein Coupled Receptors (GPCRs) Market Country Level Analysis

The G-protein coupled receptors (GPCRs) market is analysed and market size insights and trends are provided by country, product, assay type and therapeutic area as referenced above.

The countries covered in the G-protein coupled receptors (GPCRs) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the G-protein coupled receptors (GPCRs) market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing sophisticated level of healthcare facilities coupled with the rising advancement in the technology involved in healthcare sector. Concentration of major key players in this region coupled with increased focus on drug discovery & development activities.is also fostering the growth of the region in the global artificial pancreas systems market. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increased expenditure on healthcare infrastructure. Growth and expansion of biotechnology and biopharmaceutical sector is also bolstering market growth in this region.

The country section of the G-protein coupled receptors (GPCRs) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

G-protein coupled receptors (GPCRs) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the G-protein coupled receptors (GPCRs) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and G-Protein Coupled Receptors (GPCRs) Market Share Analysis

The G-protein coupled receptors (GPCRs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to G-protein coupled receptors (GPCRs) market.

The major players covered in the G-protein coupled receptors (GPCRs) market report are Abcam plc., Enzo Life Sciences, Inc., Promega Corporation., PerkinElmer Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, HD Biosciences Co., Ltd, Cisbio Bioassays, Eurofins DiscoverX Products., Actelion Pharmaceuticals Ltd, BD, Actelion Pharmaceuticals Ltd, Accure Pharma, Anchor Therapeutics., Arena Pharmaceuticals, Inc., ADDEX THERAPEUTICS, WuXi AppTec, BioInvenu,Inc., Molecular Devices, LLC. and Corning Incorporated among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-42524